More To Come
In addition to all of the changes already in process, the Inflation Reduction Act will also bring on future benefits to Medicare including:
- Prescription drug inflation rebates, which will require manufacturers to pay rebates to Medicare if the prices of covered drugs rise faster than the rate of inflation
- 49 million Medicare Part D beneficiaries will have out-of-pocket costs for prescription drugs capped at $2,000 per year starting in 2025
- Medicare will negotiate lower prices for 80 of the most expensive and popular prescription drugs by 2030
What’s Next?
As The White House continues to work towards driving down inflation, controlling healthcare related costs will be critical. One year in, the healthcare benefits of the Inflation Reduction Act are just starting to take effect with some immediate benefits to seniors and families. To learn more about what comes next, including further drug price negotiations extended vaccine coverage and benefits to low-income enrollees check out this implementation timeline.